Institutional equity research analysts covering AtkinsRéalis maintain a strong consensus buy rating on the stock, accompanied by average 12-month consensus price targets hovering around C114,withpeakbullishtargetsreachinguptoC121. These favorable pricing projections are underpinned by robust earnings outperformance, upward revisions to nuclear revenue forecasts, and strong cash conversion metrics. Analysts frequently point to the company's expanding project backlog and disciplined capital allocation strategy—including ongoing share buybacks—as primary catalysts supporting continued equity appreciation.